The primary objective of this trial is to determine the effect of Zestril(TM) (lisinopril) on blood pressure and on metabolic abnormalities that contribute to cardiovascular risk in a high group of subjects, namely hypertensive subjects with onset of hypertension prior to age 61 and a family history of hypertension. The secondary objective is to determine whether selected biochemical and physiologic tests identify hypertensive subjects who respond to Zestril.
Showing the most recent 10 out of 565 publications